179 related articles for article (PubMed ID: 8497274)
21. v-Myc, but not Max, possesses domains that function in both transcription activation and cellular transformation.
Min S; Taparowsky EJ
Oncogene; 1992 Aug; 7(8):1531-40. PubMed ID: 1630816
[TBL] [Abstract][Full Text] [Related]
22. FH3, a v-myc avian retrovirus with limited transforming ability.
Chen C; Biegalke BJ; Eisenman RN; Linial ML
J Virol; 1989 Dec; 63(12):5092-100. PubMed ID: 2555545
[TBL] [Abstract][Full Text] [Related]
23. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
Arsura M; Deshpande A; Hann SR; Sonenshein GE
Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235
[TBL] [Abstract][Full Text] [Related]
24. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
Gu W; Cechova K; Tassi V; Dalla-Favera R
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351
[TBL] [Abstract][Full Text] [Related]
25. Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus.
Fulton R; Gallagher R; Crouch D; Neil JC
J Virol; 1996 Feb; 70(2):1154-62. PubMed ID: 8551576
[TBL] [Abstract][Full Text] [Related]
26. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
[TBL] [Abstract][Full Text] [Related]
27. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
[TBL] [Abstract][Full Text] [Related]
28. Isolation and biochemical characterization of partially transformation-defective mutants of avian myelocytomatosis virus strain MC29: localization of the mutation to the myc domain of the 110,000-dalton gag-myc polyprotein.
Ramsay GM; Hayman MJ
J Virol; 1982 Mar; 41(3):745-53. PubMed ID: 6284967
[TBL] [Abstract][Full Text] [Related]
29. The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.
Wenzel A; Cziepluch C; Schürmann J; Schwab M
Prog Clin Biol Res; 1994; 385():59-66. PubMed ID: 7972238
[No Abstract] [Full Text] [Related]
30. Molecular and biological properties of MH2D12, a spontaneous mil deletion mutant of avian oncovirus MH2.
Jansen HW; Patschinsky T; Walther N; Lurz R; Bister K
Virology; 1985 Apr; 142(2):248-62. PubMed ID: 4060574
[TBL] [Abstract][Full Text] [Related]
31. Max: functional domains and interaction with c-Myc.
Kato GJ; Lee WM; Chen LL; Dang CV
Genes Dev; 1992 Jan; 6(1):81-92. PubMed ID: 1730412
[TBL] [Abstract][Full Text] [Related]
32. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.
Barrett J; Birrer MJ; Kato GJ; Dosaka-Akita H; Dang CV
Mol Cell Biol; 1992 Jul; 12(7):3130-7. PubMed ID: 1620120
[TBL] [Abstract][Full Text] [Related]
33. Avian oncovirus MH2: molecular cloning of proviral DNA and structural analysis of viral RNA and protein.
Jansen HW; Patschinsky T; Bister K
J Virol; 1983 Oct; 48(1):61-73. PubMed ID: 6310159
[TBL] [Abstract][Full Text] [Related]
34. Nucleotide sequence of avian carcinoma virus MH2: two potential onc genes, one related to avian virus MC29 and the other related to murine sarcoma virus 3611.
Kan NC; Flordellis CS; Mark GE; Duesberg PH; Papas TS
Proc Natl Acad Sci U S A; 1984 May; 81(10):3000-4. PubMed ID: 6328485
[TBL] [Abstract][Full Text] [Related]
35. Nucleotide sequence analysis of the chicken c-myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, delta gag-myc.
Watson DK; Reddy EP; Duesberg PH; Papas TS
Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2146-50. PubMed ID: 6300896
[TBL] [Abstract][Full Text] [Related]
36. Decreased DNA-binding ability of purified transformation-specific proteins from deletion mutants of the acute avian leukemia virus MC29.
Donner P; Bunte T; Greiser-Wilke I; Moelling K
Proc Natl Acad Sci U S A; 1983 May; 80(10):2861-5. PubMed ID: 6304686
[TBL] [Abstract][Full Text] [Related]
37. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation.
Prendergast GC; Lawe D; Ziff EB
Cell; 1991 May; 65(3):395-407. PubMed ID: 1840505
[TBL] [Abstract][Full Text] [Related]
38. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation.
Brough DE; Hofmann TJ; Ellwood KB; Townley RA; Cole MD
Mol Cell Biol; 1995 Mar; 15(3):1536-44. PubMed ID: 7862146
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning of proviral DNA and structural analysis of the transduced myc oncogene of avian oncovirus CMII.
Walther N; Lurz R; Patschinsky T; Jansen HW; Bister K
J Virol; 1985 May; 54(2):576-85. PubMed ID: 2985820
[TBL] [Abstract][Full Text] [Related]
40. Deletions within the transformation-specific RNA sequences of acute leukemia virus MC29 give rise to partially transformation-defective mutants.
Bister K; Ramsay GM; Hayman MJ
J Virol; 1982 Mar; 41(3):754-66. PubMed ID: 6284968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]